| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964818 | Vaccine | 2015 | 10 Pages |
Abstract
LAMP1 targeting strategy successfully enhanced the efficacy of HTNV Gn-based vaccine, which is highly immunogenic and safe, showing promise for immunoprophylaxis against HFRS. Further investigations are warranted in the future.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Dong-Bo Jiang, Yuan-Jie Sun, Lin-Feng Cheng, Ge-Fei Zhang, Chen Dong, Bo-Quan Jin, Chao-Jun Song, Ying Ma, Fang-Lin Zhang, Kun Yang,